Browse > Article

Principle and Application of Immunotherapy in Women with Recurrent Pregnancy Losses and Infertility of Implantation Failures: Intravenous Immunoglobulin G Infusion Treatment  

Kwak, Joanne Young Hee (Department of Obstetrics and Gynecology, Department of Microbiology and Immunology,Rosalind Franklin University of Medicine and Science,The Chicago Medical School)
Publication Information
Clinical and Experimental Reproductive Medicine / v.32, no.1, 2005 , pp. 1-8 More about this Journal
Keywords
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE. Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34: 93-9   DOI   ScienceOn
2 Vives A, Balasch J, Yague J, Quinto L, Ordi J, Vanrell JA. Type-l and type-2 cytokines in human decidual tissue and trophoblasts from normal and abnormal pregnancies detected by reverse transcriptase polymerase chain reaction (RT-PCR). Am J Reprod Immunol 1999; 42: 361-8   DOI   ScienceOn
3 Gleicher N, Pratt D, Dudkiewicz A. What do we really know about autoantibody abnormalities and reproductive failure: a critical review. Autoimmunity 1993; 16: 115-40   DOI   ScienceOn
4 Drake BL, Head JR. Murine trophoblast can be killed by allospecific cytotoxic T lymphocytes generated in GIBCO Opti-MEM medium. J Reprod Immunol 1989; 15: 71-7   DOI   ScienceOn
5 King A, Loke YW. Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2stimulated decidual NK cells. Cell Immunol 1990; 129: 435-48   DOI   ScienceOn
6 Lachapelle MH, Miron P, Hemmings R, Roy DC. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-34
7 Roussev RG, Higgins NG, McIntyre JA. Phenotypic characterization of normal human placental mononuclear cells. J Reprod Immunol 1993; 25: 15-29   DOI   ScienceOn
8 Beer AE, Kwak JY, Ruiz IE. Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35: 376-82   DOI
9 Beer AE, Kwak JYH, Beaman KD, Gilman-Sachs A. Antiphospholipid antibodies in women with recurrent pregnancy losses: Elicitation, expression and therapy. In: Dondero P, Johnson PM, eds. Reproductive immunology. New York: Raven Press, 1992 (vol 97)
10 Pierangeli SS, Espinola RG, Uu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-I, vascular cell adhesion molecule-I, and P-selectin. Circ Res 2001; 88: 245-50   DOI   ScienceOn
11 Heilmann L, Berg C, von Tempelhoff GP, Gehler J, Zimmer B, Wolf H. [Intravenous immunoglobulins (IVIG) in treatment of an antiphospholipid syndrome in pregnancy]. Z Geburtshilfe Neonatol 1998; 202: 164-7.
12 Gordon C, Kilby MD. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Lupus 1998; 7: 429-33   DOI   ScienceOn
13 Harris EN, Pierangeli SS. Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review. Scand J Rheumatol Suppl 1998; 107: 97-102
14 Coulam CB, Clark DA, Collins JA. Worldwide prospective collaborative observational study and metaanalysis on immunotherapy for recurrent spontaneous abortion. N Eng J Med 1994: In Press
15 Branch DW, Porter TF, Paidas MJ, Belfort MA, Gonik B. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises. J Allergy Clin Immunol 2001; 108: S 133-8   DOI   ScienceOn
16 Aoki K, Kajiura S, Matsumoto Y, et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345: 1340-2   DOI   ScienceOn
17 Christiansen OB, Mathiesen O, Husth M, et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v, immunoglobulin. Hum Reprod 1995; 10: 2690-5   DOI
18 Coulam CB. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 26: 23-7.   DOI
19 Dietrich G, Kaveri S, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/ 1diotypic network. Clin Immuno Immunopathol 1992; 62: 73-81   DOI   ScienceOn
20 Vaquero E, Lazzarin N, Valensise H, et al. Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous intmunoglobulin versus prednisone plus low-dose aspirin. Am J Reprod ImmunoI 2001;45: 174-9   DOI   ScienceOn
21 Abadia-Molina AC, Ruiz C, Montes MI, King A, Loke YW, Olivares EG. Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J Reprod Immunol 1996; 31: 109-23   DOI   ScienceOn
22 Mueller-Eckhardt G, Heine O, Neppert J, Kunzel W, Mueller-Eckhardt C. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. Vox Sang 1989; 56: 151-4   DOI   ScienceOn
23 Sherer Y, Shoenfeld Y. Antiphospholipid syndrome: insights from animal models. Curr Opin Hematol 2000; 7: 321-324   DOI   ScienceOn
24 Clark DA, Gunby J, Daya S. The use of allogeneic leukocytes or IV IgG for the treatment of patients with recurrent spontaneous abortions. Transfusion Med. Rev. 1997; 11: 85-94   DOI   ScienceOn
25 Piccinni MP, Scaletti C, Maggi E, Romagnani S. Role of hormone-controlled Thl- and Th2-type cytokines in successful pregnancy. J Neuroimmunol 2000; 109: 30-3   DOI   ScienceOn
26 Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, Okada H. Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters. Am J Reprod Immunol 1995; 33: 221-7   DOI   ScienceOn
27 Rigal D, Vermot-Desroches C, Heitz S, Bemaud J, Alfonsi F, Monier Jc. Effects of intravenous immunoglobulins (lVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-l and CD56 molecules. Clin Immunol Immunopathol 1994; 71: 309-14   DOI   ScienceOn
28 Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am J Reprod Immunol 1994; 32: 55-72   DOI   ScienceOn
29 Scott JR, Branch W, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988; 159: 1055-6   DOI
30 Kwak JYH, Beer AE, Kim SH, Mantouvalos HP. Immunopathology of the implantation site utilizing monoclonal antibodies to natural killer cells in women with recurrent pregnancy losses. AJRI 1999; 41:91-8   DOI   PUBMED   ScienceOn
31 Coulam CB. Immunotherapy for recurrent spontaneous abortion. Early Pregnancy 1995; 1: 13-26   PUBMED
32 Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000; 15: 713-8   DOI   ScienceOn
33 Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin. Fertil Steril 2000; 73: 536-40.   DOI   ScienceOn
34 Hachulla E, Piette AM, Hatron PY, Bletry O. [Aspirin and antiphospholipid syndrome]. Rev Med Interne 2000; 21: 83s-8s.   DOI   ScienceOn
35 Sher G, Matzner W, Feinman M, et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 1998; 40: 74-82   DOI   ScienceOn
36 Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002; 17: 809-16   DOI   ScienceOn
37 Coulam CB, Clark DA. Controversies in diagnosis and management of recurrent spontaneous abortion. Am J Repro Immunol 1997; 37: 279-82   DOI   ScienceOn
38 Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001;16: 855-61   DOI   ScienceOn